Guideline
Summary: Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM
Introduction Candida species are the predominant cause of fungal infections in patients treated in hospital settings, causing significant morbidity and mortality worldwide. This clinical practice guide summarises evidence-based recommendations from the European Confederation for Medical Mycology (ECMM) global guideline initiative, developed in cooperation with the International Society of Human and Animal Mycology (ISHAM) and the […]
MRSA guideline – HIS and IPS guideline
Universal or targeted screening Rescreening Test Staff screening Decolonisation In patients with eczema, dermatitis, or skin conditions – an attempt should be made to treat underlying skin conditions. A dermatology consultant could be consulted. Alternatives are – Oilatum bath additive or Oilatum plus (with added benzalkonium chloride 6% and triclosan 2%).Mupirocin prolonged or repeated use […]
C difficile Infection guideline – comparison between NICE 2021 and IDSA 2021
What does NICE guideline 2021 say about assessing and managing C difficile infection? Comparison between NICE 2021 guideline and IDSA 2021 update IDSA/SHEA focussed update 2021 NICE 2021 1st episode of CDAD -1st line Fidaxomicin 200 mg BO PO 10 days Vancomycin 125 mg QDS PO 10 days 1st episode of CDAD - 2nd line […]
NICE Guidelines and other documents – Infection
Check the most recent updates here:https://www.nice.org.uk/guidance/conditions-and-diseases/infections/covid19/products?Status=Published
